Real World Experience of Standard of Care Talquetamab in Patients with Relapsed and Refractory Multiple Myeloma

被引：0
|
作者：
Grajales-cruz, Ariel [1 ]
Graeter, Allison [2 ]
Hansen, Doris [1 ]
Puglianini, Omar Castaneda [1 ]
Vazquez-Martinez, Mariola [1 ]
Blue, Brandon [1 ]
Liu, Hien [1 ]
Ochoa-Bayona, Jose [1 ]
Freeman, Ciara [1 ]
Locke, Frederick [1 ]
Nishihori, Taiga [1 ]
Shain, Kenneth [1 ]
Baz, Rachid [1 ]
Alsina, Melissa [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Tampa, FL 33620 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-027
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Belantamab Mafadotin in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
    Dileo, Rachel
    Mewawalla, Prerna
    Patrus, Gina
    Strouse, Christopher
    Chen, Ethan
    Shaikh, Hira
    Davis, James A.
    Green, Kimberly M.
    Alkharabsheh, Omar
    Rashid, Aliya
    Pokhrel, Bidushi
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2024, 144 : 4742 - 4743
  • [22] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [23] Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma
    Biran, Noa
    Vesole, David H.
    Zhang, Shijia
    Richter, Joshua R.
    Kuo, Yen-Hong
    Schmidt, Linda
    McBride, Laura
    Anand, Palka
    Ivanovski, Kristin
    Pierre, Amy
    Kumka, Susan
    Cuccurullo, Carmela
    Siegel, David S.
    BLOOD, 2016, 128 (22)
  • [24] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Cubillas, Garcia de la Torre Damian
    Inigo, Rodriguez Belen
    Alfayate, Lobo Ana
    Menendez, Cuevas Marina
    Bolanos, Calderon Estefania
    Medina, Salazar Sissy Fiorella
    Mateo, Morales Marta
    Pena, Cortijo Ascension
    Perez, Lopez Cristina
    Polo, Zarzuela Marta
    Calo, Perez Aida
    Colas, Lahuerta Blanca
    Gomez, Alvarez Miguel
    Escribano, Serrat Silvia
    Estival, Monteliu Pablo
    Gulino, Horacio
    Daorta, Melisa
    Moreno, Paredes Nahir Daniela
    Benavente, Cuesta Celina
    HAEMATOLOGICA, 2020, 105 : 151 - 151
  • [25] REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA
    Ziff, M.
    Cheesman, S.
    Kyriakou, C.
    Mehta, A.
    Papanikolaou, X.
    Rabin, N.
    Wechalekar, A.
    Yong, K.
    Popat, R.
    HAEMATOLOGICA, 2017, 102 : 786 - 787
  • [26] Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Verona, Raluca
    Vieyra, Diego
    Casneuf, Tineke
    Fink, Damien
    Miao, Xin
    Chen, Yang
    Stephenson, Tara
    Banerjee, Arnob
    Hilder, Brandi W.
    Russell, Jeffery
    Infante, Jeffrey
    Elsayed, Yusri
    Smit, Jennifer
    Goldberg, Jenna D.
    BLOOD ADVANCES, 2023, 7 (04) : 644 - 648
  • [27] Real World Treatment of Patients with Relapsed/Refractory Myeloma
    Dimopoulos, Meletios A.
    Ntanasis-Stathopoulos, Ioannis
    Terpos, Evangelos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S24 - S27
  • [28] Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    Kim, Inho
    Jo, Jaemin
    Park, Hyunkyung
    Lee, Jeong-Ok
    Lee, Jiyun
    ANTICANCER RESEARCH, 2019, 39 (09) : 5165 - 5170
  • [29] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
    Uttervall, Katarina
    Nahi, Hareth
    Kashif, Muhammad
    Lemonakis, Konstantinos
    Rosengren, Sara
    Brolin, Janaki
    Lund, Johan
    Hansson, Markus
    BLOOD, 2022, 140 : 12605 - 12606
  • [30] A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Dileo, Rachel
    Mewawalla, Prerna
    Babu, Kalaivani
    Yin, Yue
    Strouse, Christopher
    Chen, Ethan
    Shaikh, Hira
    Davis, James A.
    Green, Kimberly M.
    Alkharabsheh, Omar
    Rashid, Aliya
    Pokhrel, Bidushi
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD CANCER JOURNAL, 2025, 15 (01):
12345